Belite Bio, Inc

NASDAQ: BLTE · Healthcare · Biotechnology

PublicHQ San Diego, CA · San DiegoCIK 0001889109Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 70DQ —GM —SS 49

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, Altman-Z · ↓ Piotroski F, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$77.6M

Employees

Market cap

$5.9B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$77.6M-$77.6M2025

Operating income-$84.2M-$84.2M2025

Total assets$780.6M$780.6M2025

Liabilities$10.1M$10.1M2025

Equity$770.5M$770.5M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Belite Bio, Inc earned -$77.6M in FY2025 net income.

Peers · Healthcare

Teleflex Incorporated77B+Erasca, Inc.——Bausch + Lomb Corporation66B Twist Bioscience Corporation70B

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Sempra$12.4B64C Realty Income Corporation$5.7B59C ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+DexCom, Inc.$4.7B87A

Key facts

CEOYu-Hsin Lin

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, CA

ExchangeNASDAQ: BLTE

Employees25

IPO date2022-04-29

Latest filings

6-K2026-06-15 6-K2026-05-20 6-K2026-04-21 6-K2026-03-31 20-F2026-03-31 6-K2026-03-02 6-K2026-01-27 6-K2025-12-02

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.